Quoin Pharmaceuticals Ltd.
Income Statement
| Line Item | FY2021 | FY2020 | FY2019 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin | — | — | — |
| Operating Expenses | |||
| Research & Development | $1.6M | $244.2K | $45.7K |
| SG&A Expense | $4.5M | $1.4M | $1.5M |
| Operating Income | — | $-4.4M | $-6.5M |
| Operating Margin | — | — | — |
| Interest Expense | $1.1M | $47.0K | — |
| Pretax Income | — | — | — |
| Income Tax Expense | — | — | — |
| Net Income | $-21.5M | $-2.1M | $-1.6M |
| Net Margin | — | — | — |
| EPS (Basic) | $-0.01 | $-0.70 | $-0.52 |
| EPS (Diluted) | $-0.01 | $-0.70 | $-0.52 |
| Shares Outstanding (Basic) | 1.58B | 1.20B | 1.20B |
| Shares Outstanding (Diluted) | 1.58B | 1.20B | 1.20B |
| Dividends Per Share | — | — | — |